5-((4-nitrosopiperazin-1-yl)methyl)pyridin-2-amine
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

5-((4-nitrosopiperazin-1-yl)methyl)pyridin-2-amine

● In Stock

Catalogue No.:VE0028283
CAS No.:N/A
Mol. Formula:C10H15N5O
Mol. Weight:221.26 g/mol

Additional information on

Parent drug

Abemaciclib

IUPAC Name

5-((4-nitrosopiperazin-1-yl)methyl)pyridin-2-amine

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

O=NN1CCN(CC2=CN=C(N)C=C2)CC1

InChI

InChI=1S/C10H15N5O/c11-10-2-1-9(7-12-10)8-14-3-5-15(13-16)6-4-14/h1-2,7H,3-6,8H2,(H2,11,12)

Description

5-((4-nitrosopiperazin-1-yl)methyl)pyridin-2-amine is a process-related impurity characterized by a nitrosated piperazine moiety attached to a 2-aminopyridine scaffold. It arises from nitrosation of piperazinyl intermediates during synthesis or storage under nitrosating conditions and presents analytical and regulatory challenges due to the nitroso functionality. Analytical identification employs HPLC with orthogonal confirmation by LC-MS and NMR, often requiring sensitive methods or derivatization for trace-level quantification. Control strategies focus on prevention of nitrosation through raw material quality, strict control of acidic and nitrosating residuals, in-process quenching and validated removal steps. Risk assessment and specification setting are critical to ensure impurity is controlled to acceptable limits.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url